Background:Â
Indicators for cholangiography were originally designed to select patients at risk for common bile duct (CBD) stones for intraoperative cholangiography.
Objective:Â
To refine these criteria to apply to the much more invasive procedure of preoperative endoscopic retrograde cholangiopancreatography (ERCP).
Design:Â
Retrospective review of selection criteria for ERCP in consecutive patients referred over 18 months following the introduction of laparoscopic cholecystectomy.
Setting:Â
Two ERCP units in adjacent teaching hospitals.
Patients:Â
Three hundred seventeen patients with gallstones and in situ gallbladders.
Intervention:Â
Common bile duct imaging at ERCP.
Main Outcome Measures:Â
Abnormalities justifying ERCP.
Results:Â
Abnormalities justifying ERCP were found in 66% of patients. This group differed significantly from those with normal ducts, with more being referred with abnormal results of all liver function tests (P<.001), jaundice (P<=.001 ), a dilated CBD on ultrasound (P<.001), or CBD stones on ultrasound (P<.001), On the other hand, patients with normal ducts were significantly more likely to have been referred with pancreatitis (P=.003) or elevated results of individual liver function tests (P<.001). A logistic regression model using age, presence of jaundice at ERCP, levels of alkaline phosphatase and albumin, and ultrasonography showing dilated ducts or visible CBD stones was found to have a specificity of 75% and a sensitivity of 89%. Past pancreatitis or elevated results of individual liver function tests were not predictive factors.
Conclusion:Â
The use of such a model rather than individual criteria would improve the selection of patients for preoperative ERCP, optimizing its role in the laparoscopic era.(Arch Surg. 1996;131:89-94)